Primmune Therapeutics Receives $8.4 Million in Second Tranche of Series A Financing

SAN DIEGO–(BUSINESS WIRE)–Primmune Therapeutics received $8.4 million in a second tranche of the Company’s Series A financing.
Click here to view original post